A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)

PHASE2CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

July 31, 2007

Conditions
Depressive Disorder, Major
Interventions
DRUG

Sertraline and Elzasonan Combination

DRUG

Sertraline

DRUG

Placebo

Trial Locations (19)

10023

Pfizer Investigational Site, New York

10614

Pfizer Investigational Site, Tallinn

44122

Pfizer Investigational Site, Beachwood

71024

Pfizer Investigational Site, Viljandi

80012

Pfizer Investigational Site, Pärnu

90210

Pfizer Investigational Site, Beverly Hills

107076

Pfizer Investigational Site, Moscow

115522

Pfizer Investigational Site, Moscow

123367

Pfizer Investigational Site, Moscow

190121

Pfizer Investigational Site, Gatchina

Pfizer Investigational Site, Saint Petersburg

191180

Pfizer Investigational Site, Saint Petersburg

192019

Pfizer Investigational Site, Saint Petersburg

193167

Pfizer Investigational Site, Saint Petersburg

197110

Pfizer Investigational Site, Saint Petersburg

214018

Pfizer Investigational Site, Smolensk

344010

Pfizer Investigational Site, Rostov-on-Don

06360

Pfizer Investigational Site, Norwich

Unknown

Pfizer Investigational Site, Santiago

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY